SEC Form D · filed August 7, 2023
RedHill Biopharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (36)
Rick D. Scruggs · Tel Aviv, L3DirectorShmuel Cabilly · Tel Aviv, L3DirectorAlla D. Felder · Tel Aviv, L3DirectorReza D. Fathi · Tel Aviv, L3ExecGuy D. Goldberg · Tel Aviv, L3ExecAdi D. Frish · Tel Aviv, L3ExecKenneth Reed · Tel Aviv, L3DirectorGilead D. Raday · Tel Aviv, L3ExecEric Swenden · Tel Aviv, L3DirectorRazi Ingber · Tel Aviv, L3ExecDror Ben-Asher · Tel Aviv, L3Exec · DirectorOfer Tsimchi · Tel Aviv, L3DirectorBruce W. Snyder · Seattle, WAExec · DirectorPeter R. Kagan · Tulsa, OKExecMohamed Arafa · Amstelveen, P7DirectorKen Johnson · Franklin, MIDirectorIngrid Mulder · Amstelveen, P7DirectorRazi Ingber · Tel Aviv, L3ExecJoshua E. Wyss · Mill Valley, CADirectorJeffrey N. Vale · Atlanta, GAExecBrandon Contino · Turtle Creek, PAExecCleon N. Daskalakis · Boston, MAExecGaurav Gambhir · Philadelphia, PADirectorAldo Zini · Turtle Creek, PADirectorJosh S. Stein · Palo Alto, CADirectorSteven A. Anderson · SOUTH PASADENA, CADirectorJohn C. Power · VACAVILLE, CADirectorBrian C. Power · VACAVILLE, CADirectorJacob S. Horne · SAN FRANCISCO, CAExecDavid Meredith · NEWPORT BEACH, CAExecRick Taketa · CORONA DEL MAR, CAExecDarren O'Brien · WAN CHAI, Hong KongDirectorSimone Blank · NEWPORT BEACH, CAExec · DirectorJost Fischer · NEWPORT BEACH, CADirectorDouglas Buchalter · Asheville, NCExecSusan C. Schnabel · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗